Nephrogenic diabetes insipidus associated with temozolomide therapy in a patient with grade IV astrocytoma
Temozolomide can in rare cases cause diabetes insipidus and, even more exceptionally, nephrogenic diabetes insipidus.The resolution of nephrogenic diabetes insipidus following the discontinuation of a high-intensity regimen is promising, and patients should not be denied temozolomide due to this complication.
Authors
- Louis Wolff (ORCID: https://orcid.org/0000-0001-9955-5433)
- Anne‐Pascale Meert (ORCID: https://orcid.org/0000-0003-1158-5502)
- Martin Manderlier
- Maxime Ilzkovitz (ORCID: https://orcid.org/0000-0003-2216-3495)
- Zayd Fargouche
Institutions
- Université Libre de Bruxelles (BE)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2025-05-27
- DOI
- https://doi.org/10.12890/2025_005463
- Citations
- 1
- Primary Topic
- Lanthanide and Transition Metal Complexes
- Type
- article
- Field-Weighted Citation Impact
- 0.52